These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 342006)

  • 1. [Use of 51Cr-labelled macrophages for the objective evaluation of macrophage migration inhibition].
    Suslov AP; Miuller U
    Biull Eksp Biol Med; 1978 Jan; 85(1):54-7. PubMed ID: 342006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro assay for uni-directional migration inhibition employing 51Cr-labelled macrophages.
    Noronha-Blob L; Huang SW
    Clin Exp Immunol; 1980 Jun; 40(3):627-32. PubMed ID: 6998620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between cytotoxic lymphocytes and cells that synthesize the macrophage migration inhibitory factor in the H-2 system].
    Suslov AP; Egorova SG; Brondz BD
    Biull Eksp Biol Med; 1975 Oct; 80(10):86-90. PubMed ID: 776251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
    Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractoriness to migration inhibitory factor of macrophages of LPS nonresponder mouse strains.
    Tagliabue A; McCoy JL; Herberman RB
    J Immunol; 1978 Oct; 121(4):1223-6. PubMed ID: 359704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The rate of macrophage inclusion in the elimination of tumor cells when administered to syngeneic animals].
    Lavrovskiĭ VA; Ustinov AS
    Eksp Onkol; 1990; 12(5):35-6. PubMed ID: 2226255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heterogeneity of murine sarcoma cells for transplantability due to their different susceptibilities to the lytic action of macrophages].
    Ustinov AS; Lavrovskiĭ VA
    Biull Eksp Biol Med; 1988 Mar; 105(3):322-4. PubMed ID: 3349171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of a continuous macrophage-like cell line to MIF.
    Newman W; Diamond B; Flomenberg P; Scharff MD; Bloom BR
    J Immunol; 1979 Nov; 123(5):2292-7. PubMed ID: 385779
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-specific resistance in mice detected by inhibition of macrophage migration.
    Vaage J; Jones RD; Brown BW
    Cancer Res; 1972 Apr; 32(4):680-7. PubMed ID: 4552377
    [No Abstract]   [Full Text] [Related]  

  • 10. [Induction of T-cell producers of the macrophage migration inhibitory factor by the products of the K-, I- and D-regions of the H-2 complex in mice].
    Kharkevich DD; Suslov AP
    Biull Eksp Biol Med; 1985 Apr; 99(4):484-6. PubMed ID: 3886043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kinetics of production of macrophage migration inhibitory factors in mixed culture of lymphocytes and tumor cells].
    Kharkevich DD; Suslov AP
    Biull Eksp Biol Med; 1982 Feb; 93(2):53-5. PubMed ID: 6461371
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of macrophage activation on the response to migration inhibitory factor (MIF).
    Leu RW; Woodson PD; Whitley SB
    J Reticuloendothel Soc; 1977 Oct; 22(4):329-40. PubMed ID: 336882
    [No Abstract]   [Full Text] [Related]  

  • 13. Migration of natural suppressor cells from bone marrow to peritoneal cavity by live BCG.
    Kato K; Yamamoto K; Kimura T
    J Immunol; 1985 Dec; 135(6):3661-8. PubMed ID: 2933452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nature of the cells regulating the production of a migration inhibition factor in C57BL/6 strain mice with low response to Candida albicans antigen].
    Vorob'ev KV; Koval'chuk LV; Gankovskaia LV
    Biull Eksp Biol Med; 1984 Nov; 98(11):601-2. PubMed ID: 6239664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mutant-specific responses by macrophage migration inhibition reactions induced by wild-type and mutant polyoma viruses and polyoma virus-infected cells.
    Szigeti R; Dalianis T; Ramqvist T; Ito Y; Klein G
    Cancer Res; 1984 Mar; 44(3):1077-80. PubMed ID: 6318980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macrophage migration inhibition test in mice with experimental amyloidosis].
    Osipova IN
    Biull Eksp Biol Med; 1980 Apr; 89(4):433-5. PubMed ID: 6992881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 18. The detection and evaluation of migration stimulatory factor in renal allograft recipients.
    Cerilli J; Fesperman DP
    Surgery; 1976 Jul; 80(1):92-7. PubMed ID: 775669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of assay conditions for macrophage migration from an agarose droplet.
    Fahlbusch B; Dornberger G
    Acta Biol Med Ger; 1979; 38(10):1453-60. PubMed ID: 44954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.